Companies / BridgeBio Oncology Therapeutics, Inc.

BridgeBio Oncology Therapeutics, Inc.

Nasdaq: BBOTCIK 1869105SOUTH SAN FRANCISCO, CA

Financials

Revenue
Net income$-134.04M
Total debt
Cash$54.06M
Diluted EPS$-4.30
Shares outstanding80.2M

Ownership

80.2M shares outstanding · as of Aug 6, 2026
0.15%Insiders
Ownership
Insiders0.15%116,670
Institutions74.08%59,391,012
Public float25.78%20,666,585

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 6

View all →
Insider% of sharesShares
Beltran PedroChief Scientific Officer
0.06%46,670
Ben YongChief Med & Dev Officer
0.06%46,670
Mehra UneekChief Financial Officer
0.03%23,330
Wallace Eli M.CEOChief Executive Officer · Director

Institutional holders 57

View all →

Activity

Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).
DateActorActionSecurityValueShares ΔPosition afterImpact
Q1 2026
as of
Adage Capital Partners Gp, L.L.C.
13F manager
TrimCommon Stock$-8.95M-1.0M
-71.43%
400,000
0.50% of shares
medium
Q2 2026
as of
State Street Corporation
13F manager
AddCommon Stock$6.24M+818K
+374.88%
1,036,569
1.29% of shares
medium
Q1 2026
as of
Laurion Capital Management LP
13F manager
AddCommon Stock$4.10M+458K
+31.24%
1,922,656
2.40% of shares
low
Q1 2026
as of
Schroder Investment Management Group
13F manager
NewCommon Stock$2.16M+249K
249,161
0.31% of shares
low
Q1 2026
as of
Granahan Investment Management, LLC
13F manager
NewCommon Stock$2.07M+231K
231,040
0.29% of shares
low
Q1 2026
as of
Novo Holdings A/S
13F manager
AddCommon Stock$2.01M+225K
+11.45%
2,185,923
2.73% of shares
low
Q1 2026
as of
HighVista Strategies LLC
13F manager
TrimCommon Stock$-1.35M-151K
-65.90%
78,187
0.10% of shares
low
Q1 2026
as of
Hudson Bay Capital Management LP
13F manager
NewCommon Stock$984.5K+110K
110,000
0.14% of shares
low

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
BBOTCommon StockEquity107924102BBG01L3GYF02